z-logo
Premium
A new oral kallikrein inhibitor for long‐term prophylaxis of hereditary angioedema
Author(s) -
Doña Inmaculada,
Torres María José
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14798
Subject(s) - icatibant , bradykinin , medicine , hereditary angioedema , kallikrein , tranexamic acid , angioedema , danazol , factor xii , c1 inhibitor , immunology , pharmacology , receptor , surgery , coagulation , chemistry , enzyme , endometriosis , biochemistry , blood loss

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom